Age-Related Macular Degeneration (ARMD) Completed Phase 2 Trials for Sirolimus (DB00877)

Also known as: Age-related macular degeneration / Macular Degeneration / Senile macular degeneration / Macular degeneration senile / Macular degeneration (senile) of retina, unspecified

IndicationStatusPhase
DBCOND0034150 (Age-Related Macular Degeneration (ARMD))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02357342Sirolimus Versus Anti-Vascular Endothelial Growth Factor (antiVEGF) for Wet AMDTreatment
NCT00304954Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular DegenerationTreatment